Citadel Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $207M | Buy |
7,359,865
+1,952,489
| +36% | +$52M | 0.03% | 443 |
|
|
2025
Q4 | $135M | Sell |
5,407,376
-4,879,551
| -47% | -$123M | 0.02% | 687 |
|
|
2025
Q3 | $262M | Sell |
10,286,927
-4,579,276
| -31% | -$113M | 0.04% | 372 |
|
|
2025
Q2 | $360M | Buy |
14,866,203
+7,831,434
| +111% | +$183M | 0.06% | 226 |
|
|
2025
Q1 | $178M | Sell |
7,034,769
-7,838,540
| -53% | -$205M | 0.03% | 410 |
|
|
2024
Q4 | $395M | Buy |
14,873,309
+6,811,116
| +84% | +$185M | 0.07% | 199 |
|
|
2024
Q3 | $233M | Sell |
8,062,193
-12,333,440
| -60% | -$360M | 0.05% | 312 |
|
|
2024
Q2 | $571M | Buy |
20,395,633
+7,886,096
| +63% | +$217M | 0.12% | 108 |
|
|
2024
Q1 | $347M | Buy |
12,509,537
+879,463
| +8% | +$24.4M | 0.07% | 209 |
|
|
2023
Q4 | $335M | Buy |
11,630,074
+9,343,112
| +409% | +$282M | 0.07% | 192 |
|
|
2023
Q3 | $75.9M | Buy |
2,286,962
+162,461
| +8% | +$5.75M | 0.02% | 783 |
|
|
2023
Q2 | $77.9M | Buy |
2,124,501
+600,673
| +39% | +$23.4M | 0.02% | 767 |
|
|
2023
Q1 | $62.2M | Buy |
1,523,828
+330,884
| +28% | +$14.3M | 0.01% | 912 |
|
|
2022
Q4 | $61.1M | Sell |
1,192,944
-2,858,017
| -71% | -$137M | 0.01% | 971 |
|
|
2022
Q3 | $177M | Buy |
4,050,961
+3,121,361
| +336% | +$152M | 0.04% | 354 |
|
|
2022
Q2 | $48.7M | Sell |
929,600
-499,168
| -35% | -$25.4M | 0.01% | 1035 |
|
|
2022
Q1 | $74M | Buy |
1,428,768
+447,036
| +46% | +$23.2M | 0.02% | 828 |
|
|
2021
Q4 | $58M | Sell |
981,732
-4,336,153
| -82% | -$215M | 0.01% | 1054 |
|
|
2021
Q3 | $229M | Buy |
5,317,885
+4,608,491
| +650% | +$204M | 0.05% | 300 |
|
|
2021
Q2 | $27.8M | Sell |
709,394
-7,448,658
| -91% | -$290M | 0.01% | 1700 |
|
|
2021
Q1 | $296M | Buy |
8,158,052
+2,246,608
| +38% | +$79.8M | 0.07% | 179 |
|
|
2020
Q4 | $218M | Buy |
5,911,444
+4,670,668
| +376% | +$171M | 0.06% | 236 |
|
|
2020
Q3 | $43.2M | Buy |
1,240,776
+3,884
| +0.3% | +$136K | 0.01% | 966 |
|
|
2020
Q2 | $38.4M | Sell |
1,236,892
-7,375,041
| -86% | -$251M | 0.01% | 974 |
|
|
2020
Q1 | $267M | Buy |
8,611,933
+5,566,896
| +183% | +$190M | 0.12% | 87 |
|
|
2019
Q4 | $113M | Buy |
3,045,037
+1,233,718
| +68% | +$43.9M | 0.05% | 343 |
|
|
2019
Q3 | $61.7M | Buy |
1,811,319
+1,203,839
| +198% | +$43.8M | 0.03% | 636 |
|
|
2019
Q2 | $25M | Sell |
607,480
-349,101
| -36% | -$13.9M | 0.01% | 1218 |
|
|
2019
Q1 | $38.5M | Buy |
956,581
+340,901
| +55% | +$13.7M | 0.02% | 849 |
|
|
2018
Q4 | $25.5M | Sell |
615,680
-3,956,306
| -87% | -$164M | 0.01% | 1048 |
|
|
2018
Q3 | $191M | Buy |
4,571,986
+4,514,509
| +7,854% | +$174M | 0.09% | 183 |
|
|
2018
Q2 | $1.98M | Sell |
57,477
-70,543
| -55% | -$2.41M | ﹤0.01% | 4131 |
|
|
2018
Q1 | $4.31M | Sell |
128,020
-82,386
| -39% | -$2.83M | ﹤0.01% | 2629 |
|
|
2017
Q4 | $7.23M | Sell |
210,406
-7,089,023
| -97% | -$242M | ﹤0.01% | 2051 |
|
|
2017
Q3 | $247M | Buy |
7,299,429
+6,007,603
| +465% | +$193M | 0.19% | 63 |
|
|
2017
Q2 | $41.2M | Buy |
1,291,826
+1,018,686
| +373% | +$32.1M | 0.03% | 590 |
|
|
2017
Q1 | $8.87M | Buy |
273,140
+20,491
| +8% | +$646K | 0.01% | 1529 |
|
|
2016
Q4 | $7.79M | Buy |
252,649
+240,961
| +2,062% | +$7.36M | 0.01% | 1578 |
|
|
2016
Q3 | $376K | Sell |
11,688
-1,045,732
| -99% | -$35M | ﹤0.01% | 5304 |
|
|
2016
Q2 | $35.3M | Sell |
1,057,420
-426,395
| -29% | -$13.6M | 0.04% | 488 |
|
|
2016
Q1 | $41.7M | Sell |
1,483,815
-2,863,114
| -66% | -$81.8M | 0.05% | 368 |
|
|
2015
Q4 | $133M | Buy |
4,346,929
+3,515,460
| +423% | +$111M | 0.15% | 132 |
|
|
2015
Q3 | $24.8M | Sell |
831,469
-1,665,986
| -67% | -$53.4M | 0.02% | 761 |
|
|
2015
Q2 | $79.4M | Sell |
2,497,455
-1,296,893
| -34% | -$42.3M | 0.07% | 305 |
|
|
2015
Q1 | $125M | Buy |
3,794,348
+1,489,035
| +65% | +$47.3M | 0.12% | 171 |
|
|
2014
Q4 | $68.1M | Sell |
2,305,313
-4,710,832
| -67% | -$135M | 0.07% | 329 |
|
|
2014
Q3 | $197M | Buy |
7,016,145
+3,600,733
| +105% | +$101M | 0.21% | 71 |
|
|
2014
Q2 | $96.2M | Sell |
3,415,412
-698,814
| -17% | -$19.9M | 0.11% | 177 |
|
|
2014
Q1 | $125M | Sell |
4,114,226
-3,059,610
| -43% | -$91.2M | 0.15% | 114 |
|
|
2013
Q4 | $208M | Buy |
7,173,836
+7,079,027
| +7,467% | +$206M | 0.27% | 47 |
|
|
2013
Q3 | $2.58M | Sell |
94,809
-9,022,015
| -99% | -$245M | ﹤0.01% | 2167 |
|
|
2013
Q2 | $242M | Buy |
+9,116,824
| New | +$252M | 0.42% | 20 |
|
Other funds holding PFE
VCM
VPM
Citadel Advisors's PFE Position: Q1 2026 in Review
Citadel Advisors increased its Pfizer (PFE) stake by 36% in Q1 2026, buying an estimated $52M and bringing the position to 7,359,865 shares worth $207M. The position accounts for 0.03% of the portfolio, ranked #443.
Citadel Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $571M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Citadel Advisors held 7,359,865 shares of Pfizer worth $207M as of Q1 2026.
- Citadel Advisors bought 1,952,489 Pfizer shares in Q1 2026, an estimated $52M.
- Pfizer made up 0.03% of Citadel Advisors's portfolio in Q1 2026, its #443 holding.
- Citadel Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Pfizer position peaked at $571M in Q2 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.